Skip to main content
SpringerLink
Log in

Premalignant Lesions of the Prostate

  • Chapter
  • First Online:
Prostate Cancer: A Comprehensive Perspective

  • 2966 Accesses

Abstract

It is now universally accepted that high-grade prostatic intraepithelial neoplasia (HGPIN) is the key preneoplastic lesion associated with prostate cancer, and it has a well recognized characteristic morphology, with variants and immunochemical expression pattern. Low-grade PIN has not yet been accepted as a preneoplastic lesion. Because of the high incidence of prostate cancer, HGPIN is also extremely common. When first identified on needle biopsies, it had a high predictive value for the later development of prostate cancer: however, this association is being lost in the era of extended biopsies as most tumors are sampled at first biopsy procedure. However, multiple foci of HGPIN appear more predictive of later malignancy than single foci, and this has implications for patient surveillance.

Atypical acinar proliferations are not true preneoplastic lesions but merely statements of pathological uncertainty about the presence of carcinoma. However, their identification is important because of a strong association with the presence of malignancy on later biopsy.

Intraductal carcinoma is an unusual and rare entity, which may represent spread of a preexisting carcinoma down prostatic ducts thus mimicking a preneoplastic lesion. It is nearly always found associated with invasive malignancy. It has been suggested that proliferative inflammatory atrophy is a premalignant lesion and occurs at a stage before PIN, though this is unproven.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 229.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Bouquot JE, Whitaker SB. Oral leukoplakia–rationale for diagnosis and prognosis of its clinical subtypes or “phases”. Quintessence Int. 1994;25(2):133–40.

    PubMed  CAS  Google Scholar 

  2. Slaughter DP, Southwick HW, Smejkal W. Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer. 1953;6(5):963–8.

    Article  PubMed  CAS  Google Scholar 

  3. Andrews GS. Latent carcinoma of the prostate. J Clin Pathol. 1949;2(3):197–208.

    Article  PubMed  CAS  Google Scholar 

  4. Helpap B. The biological significance of atypical hyperplasia of the prostate. Virchows Arch A Pathol Anat Histol. 1980;387(3):307–17.

    Article  PubMed  CAS  Google Scholar 

  5. McNeal JE. Morphogenesis of prostatic carcinoma. Cancer. 1965;18(12):1659–66.

    Article  PubMed  CAS  Google Scholar 

  6. McNeal JE, Bostwick DG. Intraductal dysplasia: a premalignant lesion of the prostate. Hum Pathol. 1986;17(1):64–71.

    Article  PubMed  CAS  Google Scholar 

  7. NNPCD Project. Prostatic Intraepithelial Neoplasia: significance and correlation with prostate-specific antigen and transrectal ultrasound. Urology. 1989;34(suppl):69.

    Google Scholar 

  8. Giannulis I, Montironi R, Galluzzi CM, de Nictolis M, Diamanti L. Frequency and location of mitoses in prostatic intraepithelial neoplasia (PIN). Anticancer Res. 1993;13(6B):2447–51.

    PubMed  CAS  Google Scholar 

  9. Epstein JI, Grignon DJ, Humphrey PA, et al. Interobserver reproducibility in the diagnosis of prostatic intraepithelial neoplasia. Am J Surg Pathol. 1995;19(8):873–86.

    Article  PubMed  CAS  Google Scholar 

  10. Clark J, Attard G, Jhavar S, et al. Complex patterns of ETS gene alteration arise during cancer development in the human prostate. Oncogene. 2008;27(14):1993–2003.

    Article  PubMed  CAS  Google Scholar 

  11. Rioux-Leclercq NC, Epstein JI. Unusual morphologic patterns of basal cell hyperplasia of the prostate. Am J Surg Pathol. 2002;26(2):237–43.

    Article  PubMed  Google Scholar 

  12. Berney DM, Fisher G, Kattan MW, et al. Pitfalls in the diagnosis of prostatic cancer: retrospective review of 1791 cases with clinical outcome. Histopathology. 2007;51(4):452–7.

    Article  PubMed  CAS  Google Scholar 

  13. Srodon M, Epstein JI. Central zone histology of the prostate: a mimicker of high-grade prostatic intraepithelial neoplasia. Hum Pathol. 2002;33(5):518–23.

    Article  PubMed  Google Scholar 

  14. Bostwick DG, Ma J. Over-diagnosis of high-grade prostatic intraepithelial neoplasia: a prospective study of 251 cases. BJU Int. 2007;100(5):1036–9.

    Article  PubMed  Google Scholar 

  15. Bostwick DG, Amin MB, Dundore P, Marsh W, Schultz DS. Architectural patterns of high-grade prostatic intraepithelial neoplasia. Hum Pathol. 1993;24(3):298–310.

    Article  PubMed  CAS  Google Scholar 

  16. Reyes AO, Swanson PE, Carbone JM, Humphrey PA. Unusual histologic types of high-grade prostatic intraepithelial neoplasia. Am J Surg Pathol. 1997;21(10):1215–22.

    Article  PubMed  CAS  Google Scholar 

  17. Berman DM, Yang J, Epstein JI. Foamy gland high-grade prostatic intraepithelial neoplasia. Am J Surg Pathol. 2000;24(1):140–4.

    Article  PubMed  CAS  Google Scholar 

  18. Argani P, Epstein JI. Inverted (Hobnail) high-grade prostatic intraepithelial neoplasia (PIN): report of 15 cases of a previously undescribed pattern of high-grade PIN. Am J Surg Pathol. 2001;25(12):1534–9.

    Article  PubMed  CAS  Google Scholar 

  19. Wu CL, Yang XJ, Tretiakova M, et al. Analysis of alpha-methylacyl-CoA racemase (P504S) expression in high-grade prostatic intraepithelial neoplasia. Hum Pathol. 2004;35(8):1008–13.

    Article  PubMed  CAS  Google Scholar 

  20. Ananthanarayanan V, Deaton RJ, Yang XJ, Pins MR, Gann PH. Alpha-methylacyl-CoA racemase (AMACR) expression in normal prostatic glands and high-grade prostatic intraepithelial neoplasia (HGPIN): association with diagnosis of prostate cancer. Prostate. 2005;63(4):341–6.

    Article  PubMed  CAS  Google Scholar 

  21. Zhou M, Chinnaiyan AM, Kleer CG, Lucas PC, Rubin MA. Alpha-methylacyl-CoA racemase: a novel tumor marker over-expressed in several human cancers and their precursor lesions. Am J Surg Pathol. 2002;26(7):926–31.

    Article  PubMed  Google Scholar 

  22. Bostwick DG, Brawer MK. Prostatic intra-epithelial neoplasia and early invasion in prostate cancer. Cancer. 1987;59(4):788–94.

    Article  PubMed  CAS  Google Scholar 

  23. Signoretti S, Waltregny D, Dilks J, et al. p63 is a prostate basal cell marker and is required for prostate development. Am J Pathol. 2000;157(6):1769–75.

    Article  PubMed  CAS  Google Scholar 

  24. Davis LD, Zhang W, Merseburger A, et al. p63 expression profile in normal and malignant prostate epithelial cells. Anticancer Res. 2002;22(6C):3819–25.

    PubMed  CAS  Google Scholar 

  25. Wojno KJ, Epstein JI. The utility of basal cell-specific anti-cytokeratin antibody (34 beta E12) in the diagnosis of prostate cancer. A review of 228 cases. Am J Surg Pathol. 1995;19(3):251–60.

    Article  PubMed  CAS  Google Scholar 

  26. Yang XJ, Lecksell K, Gaudin P, Epstein JI. Rare expression of high-molecular-weight cytokeratin in adenocarcinoma of the prostate gland: a study of 100 cases of metastatic and locally advanced prostate cancer. Am J Surg Pathol. 1999;23(2):147–52.

    Article  PubMed  CAS  Google Scholar 

  27. Sakr WA, Grignon DJ, Crissman JD, et al. High grade prostatic intraepithelial neoplasia (HGPIN) and prostatic adenocarcinoma between the ages of 20-69: an autopsy study of 249 cases. In Vivo. 1994;8(3):439–43.

    PubMed  CAS  Google Scholar 

  28. Prange W, Erbersdobler A, Hammerer P, et al. High-grade prostatic intraepithelial neoplasia in cystoprostatectomy specimens. Eur Urol. 2001;39 Suppl 4:30–1.

    Article  PubMed  Google Scholar 

  29. Wiley EL, Davidson P, McIntire DD, Sagalowsky AI. Risk of concurrent prostate cancer in cystoprostatectomy specimens is related to volume of high-grade prostatic intraepithelial neoplasia. Urology. 1997;49(5):692–6.

    Article  PubMed  CAS  Google Scholar 

  30. Qian J, Wollan P, Bostwick DG. The extent and multicentricity of high-grade prostatic intraepithelial neoplasia in clinically localized prostatic adenocarcinoma. Hum Pathol. 1997;28(2):143–8.

    Article  PubMed  CAS  Google Scholar 

  31. Gaudin PB, Sesterhenn IA, Wojno KJ, Mostofi FK, Epstein JI. Incidence and clinical significance of high-grade prostatic intraepithelial neoplasia in TURP specimens. Urology. 1997;49(4):558–63.

    Article  PubMed  CAS  Google Scholar 

  32. Pacelli A, Bostwick DG. Clinical significance of high-grade prostatic intraepithelial neoplasia in transurethral resection specimens. Urology. 1997;50(3):355–9.

    Article  PubMed  CAS  Google Scholar 

  33. Skjorten FJ, Berner A, Harvei S, Robsahm TE, Tretli S. Prostatic intraepithelial neoplasia in surgical resections: relationship to coexistent adenocarcinoma and atypical adenomatous hyperplasia of the prostate. Cancer. 1997;79(6):1172–9.

    Article  PubMed  CAS  Google Scholar 

  34. Epstein JI, Cho KR, Quinn BD. Relationship of severe dysplasia to stage A (incidental) adenocarcinoma of the prostate. Cancer. 1990;65(10):2321–7.

    Article  PubMed  CAS  Google Scholar 

  35. Hoedemaeker RF, Kranse R, Rietbergen JB, et al. Evaluation of prostate needle biopsies in a population-based screening study: the impact of borderline lesions. Cancer. 1999;85(1):145–52.

    Article  PubMed  CAS  Google Scholar 

  36. Feneley MR, Busch C. Precursor lesions for prostate cancer. J R Soc Med. 1997;90(10):533–9.

    PubMed  CAS  Google Scholar 

  37. Richie JP, Kavoussi LR, Ho GT, et al. Prostate cancer screening: role of the digital rectal examination and prostate-specific antigen. Ann Surg Oncol. 1994;1(2):117–20.

    Article  PubMed  CAS  Google Scholar 

  38. Reyes AO, Humphrey PA. Diagnostic effect of complete histologic sampling of prostate needle biopsy specimens. Am J Clin Pathol. 1998;109(4):416–22.

    PubMed  CAS  Google Scholar 

  39. Bostwick DG, Qian J, Frankel K. The incidence of high grade prostatic intraepithelial neoplasia in needle biopsies. J Urol. 1995;154(5):1791–4.

    Article  PubMed  CAS  Google Scholar 

  40. Lee F, Torp-Pedersen ST, Carroll JT, et al. Use of transrectal ultrasound and prostate-specific antigen in diagnosis of prostatic intraepithelial neoplasia. Urology. 1989;34(6 Suppl):4–8.

    PubMed  CAS  Google Scholar 

  41. Gohji K, Okamoto M, Morisue K, Fujii A. Usefulness of digital rectal examination, serum prostate-specific antigen, transrectal ultrasonography and systematic prostate biopsy for the detection of organ-confined prostate cancer. Int J Urol. 1995;2(2):116–20.

    Article  PubMed  CAS  Google Scholar 

  42. Brawer MK. Prostatic intraepithelial neoplasia and prostate-specific antigen. Urology. 1989;34(6 Suppl):62–5.

    PubMed  CAS  Google Scholar 

  43. Thorson P, Vollmer RT, Arcangeli C, Keetch DW, Humphrey PA. Minimal carcinoma in prostate needle biopsy specimens: diagnostic features and radical prostatectomy follow-up. Mod Pathol. 1998;11(6):543–51.

    PubMed  CAS  Google Scholar 

  44. Mostofi FK, Murphy GP, Mettlin C, et al. Pathology review in an early prostate cancer detection program: results from the American Cancer Society-National Prostate Cancer Detection Project. Prostate. 1995;27(1):7–12.

    Article  PubMed  CAS  Google Scholar 

  45. Hu JC, Palapattu GS, Kattan MW, Scardino PT, Wheeler TM. The association of selected pathological features with prostate cancer in a single-needle biopsy accession. Hum Pathol. 1998;29(12):1536–8.

    Article  PubMed  CAS  Google Scholar 

  46. Rosser CJ, Broberg J, Case D, Eskew LA, McCullough D. Detection of high-grade prostatic intraepithelial neoplasia with the five-region biopsy technique. Urology. 1999;54(5):853–6.

    Article  PubMed  CAS  Google Scholar 

  47. Ananthanarayanan V, Pins MR, Meyer RE, Gann PH. Immunohistochemical assays in prostatic biopsies processed in Bouin’s fixative. J Clin Pathol. 2005;58(3):322–4.

    Article  PubMed  CAS  Google Scholar 

  48. Chan TY, Epstein JI. Patient and urologist driven second opinion of prostate needle biopsies. J Urol. 2005;174(4 Pt 1):1390–4; discussion 4; author reply 4.

    Article  PubMed  Google Scholar 

  49. Silvestri F, Bussani R, Pavletic N, Bassan F. Neoplastic and borderline lesions of the prostate: autopsy study and epidemiological data. Pathol Res Pract. 1995;191(9):908–16.

    Article  PubMed  CAS  Google Scholar 

  50. Bostwick DG, Qian J. High-grade prostatic intraepithelial neoplasia. Mod Pathol. 2004;17(3):360–79.

    Article  PubMed  Google Scholar 

  51. Haggman MJ, Macoska JA, Wojno KJ, Oesterling JE. The relationship between prostatic intraepithelial neoplasia and prostate cancer: critical issues. J Urol. 1997;158(1):12–22.

    Article  PubMed  CAS  Google Scholar 

  52. Qian J, Bostwick DG. The extent and zonal location of prostatic intraepithelial neoplasia and atypical adenomatous hyperplasia: relationship with carcinoma in radical prostatectomy specimens. Pathol Res Pract. 1995;191(9):860–7.

    Article  PubMed  CAS  Google Scholar 

  53. McNeal JE, Villers A, Redwine EA, Freiha FS, Stamey TA. Microcarcinoma in the prostate: its association with duct-acinar dysplasia. Hum Pathol. 1991;22(7):644–52.

    Article  PubMed  CAS  Google Scholar 

  54. Baltaci S, Orhan D, Ozer G, Tolunay O, Gogous O. Bcl-2 proto-oncogene expression in low- and high-grade prostatic intraepithelial neoplasia. BJU Int. 2000;85(1):155–9.

    Article  PubMed  CAS  Google Scholar 

  55. Miet SM, Neyra M, Jaques R, et al. RER(+) phenotype in prostate intra-epithelial neoplasia associated with human prostate-carcinoma development. Int J Cancer. 1999;82(5):635–9.

    Article  PubMed  CAS  Google Scholar 

  56. Darson MF, Pacelli A, Roche P, et al. Human glandular kallikrein 2 (hK2) expression in prostatic intraepithelial neoplasia and adenocarcinoma: a novel prostate cancer marker. Urology. 1997;49(6):857–62.

    Article  PubMed  CAS  Google Scholar 

  57. Maygarden SJ, Strom S, Ware JL. Localization of epidermal growth factor receptor by immunohistochemical methods in human prostatic carcinoma, prostatic intraepithelial neoplasia, and benign hyperplasia. Arch Pathol Lab Med. 1992;116(3):269–73.

    PubMed  CAS  Google Scholar 

  58. Baretton GB, Vogt T, Blasenbreu S, Lohrs U. Comparison of DNA ploidy in prostatic intraepithelial neoplasia and invasive carcinoma of the prostate: an image cytometric study. Hum Pathol. 1994;25(5):506–13.

    Article  PubMed  CAS  Google Scholar 

  59. Gopalan A, Leversha MA, Satagopan JM, et al. TMPRSS2-ERG gene fusion is not associated with outcome in patients treated by prostatectomy. Cancer Res. 2009;69(4):1400–6.

    Article  PubMed  CAS  Google Scholar 

  60. Cerveira N, Ribeiro FR, Peixoto A, et al. TMPRSS2-ERG gene fusion causing ERG overexpression precedes chromosome copy number changes in prostate carcinomas and paired HGPIN lesions. Neoplasia. 2006;8(10):826–32.

    Article  PubMed  CAS  Google Scholar 

  61. Perner S, Mosquera JM, Demichelis F, et al. TMPRSS2-ERG fusion prostate cancer: an early molecular event associated with invasion. Am J Surg Pathol. 2007;31(6):882–8.

    Article  PubMed  Google Scholar 

  62. Qian J, Bostwick DG, Takahashi S, et al. Chromosomal anomalies in prostatic intraepithelial neoplasia and carcinoma detected by fluorescence in situ hybridization. Cancer Res. 1995;55(22):5408–14.

    PubMed  CAS  Google Scholar 

  63. Kim NW, Hruszkewycz AM. Telomerase activity modulation in the prevention of prostate cancer. Urology. 2001;57(4 Suppl 1):148–53.

    Article  PubMed  CAS  Google Scholar 

  64. Sakr WA, Haas GP, Cassin BF, Pontes JE, Crissman JD. The frequency of carcinoma and intraepithelial neoplasia of the prostate in young male patients. J Urol. 1993;150(2 Pt 1):379–85.

    PubMed  CAS  Google Scholar 

  65. Lefkowitz GK, Sidhu GS, Torre P, Lepor H, Taneja SS. Is repeat prostate biopsy for high-grade prostatic intraepithelial neoplasia necessary after routine 12-core sampling? Urology. 2001;58(6):999–1003.

    Article  PubMed  CAS  Google Scholar 

  66. Brawer MK, Bigler SA, Sohlberg OE, Nagle RB, Lange PH. Significance of prostatic intraepithelial neoplasia on prostate needle biopsy. Urology. 1991;38(2):103–7.

    Article  PubMed  CAS  Google Scholar 

  67. Weinstein MH, Epstein JI. Significance of high-grade prostatic intraepithelial neoplasia on needle biopsy. Hum Pathol. 1993;24(6):624–9.

    Article  PubMed  CAS  Google Scholar 

  68. Keetch DW, Humphrey P, Stahl D, Smith DS, Catalona WJ. Morphometric analysis and clinical followup of isolated prostatic intraepithelial neoplasia in needle biopsy of the prostate. J Urol. 1995;154(2 Pt 1):347–51.

    PubMed  CAS  Google Scholar 

  69. Davidson D, Bostwick DG, Qian J, et al. Prostatic intraepithelial neoplasia is a risk factor for adenocarcinoma: predictive accuracy in needle biopsies. J Urol. 1995;154(4):1295–9.

    Article  PubMed  CAS  Google Scholar 

  70. Aboseif S, Shinohara K, Weidner N, Narayan P, Carroll PR. The significance of prostatic intra-epithelial neoplasia. Br J Urol. 1995;76(3):355–9.

    Article  PubMed  CAS  Google Scholar 

  71. Ellis WJ, Brawer MK. Repeat prostate needle biopsy: who needs it? J Urol. 1995;153(5):1496–8.

    Article  PubMed  CAS  Google Scholar 

  72. Raviv G, Janssen T, Zlotta AR, et al. Prostatic intraepithelial neoplasia: influence of clinical and pathological data on the detection of prostate cancer. J Urol. 1996;156(3):1050–4; discussion 4–5.

    Article  PubMed  CAS  Google Scholar 

  73. Langer JE, Rovner ES, Coleman BG, et al. Strategy for repeat biopsy of patients with prostatic intraepithelial neoplasia detected by prostate needle biopsy. J Urol. 1996;155(1):228–31.

    Article  PubMed  CAS  Google Scholar 

  74. Perachino M, di Ciolo L, Barbetti V, et al. Results of rebiopsy for suspected prostate cancer in symptomatic men with elevated PSA levels. Eur Urol. 1997;32(2):155–9.

    PubMed  CAS  Google Scholar 

  75. Kamoi K, Troncoso P, Babaian RJ. Strategy for repeat biopsy in patients with high grade prostatic intraepithelial neoplasia. J Urol. 2000;163(3):819–23.

    Article  PubMed  CAS  Google Scholar 

  76. O’Dowd GJ, Miller MC, Orozco R, Veltri RW. Analysis of repeated biopsy results within 1 year after a noncancer diagnosis. Urology. 2000;55(4):553–9.

    Article  PubMed  Google Scholar 

  77. Alsikafi NF, Brendler CB, Gerber GS, Yang XJ. High-grade prostatic intraepithelial neoplasia with adjacent atypia is associated with a higher incidence of cancer on subsequent needle biopsy than high-grade prostatic intraepithelial neoplasia alone. Urology. 2001;57(2):296–300.

    Article  PubMed  CAS  Google Scholar 

  78. Vis AN, Hoedemaeker RF, Roobol M, Schroder FH, van der Kwast TH. The predictive value for prostate cancer of lesions that raise suspicion of concomitant carcinoma: an evaluation from a randomized, population-based study of screening for prostate cancer. Cancer. 2001;92(3):524–34.

    Article  PubMed  CAS  Google Scholar 

  79. Kronz JD, Allan CH, Shaikh AA, Epstein JI. Predicting cancer following a diagnosis of high-grade prostatic intraepithelial neoplasia on needle biopsy: data on men with more than one follow-up biopsy. Am J Surg Pathol. 2001;25(8):1079–85.

    Article  PubMed  CAS  Google Scholar 

  80. Borboroglu PG, Sur RL, Roberts JL, Amling CL. Repeat biopsy strategy in patients with atypical small acinar proliferation or high grade prostatic intraepithelial neoplasia on initial prostate needle biopsy. J Urol. 2001;166(3):866–70.

    Article  PubMed  CAS  Google Scholar 

  81. Park S, Shinohara K, Grossfeld GD, Carroll PR. Prostate cancer detection in men with prior high grade prostatic intraepithelial neoplasia or atypical prostate biopsy. J Urol. 2001;165(5):1409–14.

    Article  PubMed  CAS  Google Scholar 

  82. Maatman TJ, Papp SR, Carothers GG, Shockley KF. The critical role of patient follow-up after receiving a diagnosis of prostatic intraepithelial neoplasia. Prostate Cancer Prostatic Dis. 2001;4(1):63–6.

    Article  PubMed  Google Scholar 

  83. San Francisco IF, Olumi AF, Kao J, Rosen S, DeWolf WC. Clinical management of prostatic intraepithelial neoplasia as diagnosed by extended needle biopsies. BJU Int. 2003;91(4):350–4.

    Article  PubMed  CAS  Google Scholar 

  84. Goeman L, Joniau S, Ponette D, et al. Is low-grade prostatic intraepithelial neoplasia a risk factor for cancer? Prostate Cancer Prostatic Dis. 2003;6(4):305–10.

    Article  PubMed  CAS  Google Scholar 

  85. Roscigno M, Scattoni V, Freschi M, et al. Monofocal and plurifocal high-grade prostatic intraepithelial neoplasia on extended prostate biopsies: factors predicting cancer detection on extended repeat biopsy. Urology. 2004;63(6):1105–10.

    Article  PubMed  Google Scholar 

  86. Postma R, Roobol M, Schroder FH, van der Kwast TH. Lesions predictive for prostate cancer in a screened population: first and second screening round findings. Prostate. 2004;61(3):260–6.

    Article  PubMed  Google Scholar 

  87. Abdel-Khalek M, El-Baz M, Ibrahiem el-H. Predictors of prostate cancer on extended biopsy in patients with high-grade prostatic intraepithelial neoplasia: a multivariate analysis model. BJU Int. 2004;94(4):528–33.

    Article  PubMed  Google Scholar 

  88. Herawi M, Kahane H, Cavallo C, Epstein JI. Risk of prostate cancer on first re-biopsy within 1 year following a diagnosis of high grade prostatic intraepithelial neoplasia is related to the number of cores sampled. J Urol. 2006;175(1):121–4.

    Article  PubMed  Google Scholar 

  89. Gokden N, Roehl KA, Catalona WJ, Humphrey PA. High-grade prostatic intraepithelial neoplasia in needle biopsy as risk factor for detection of adenocarcinoma: current level of risk in screening population. Urology. 2005;65(3):538–42.

    Article  PubMed  Google Scholar 

  90. Netto GJ, Epstein JI. Widespread high-grade prostatic intraepithelial neoplasia on prostatic needle biopsy: a significant likelihood of subsequently diagnosed adenocarcinoma. Am J Surg Pathol. 2006;30(9):1184–8.

    Article  PubMed  Google Scholar 

  91. Akhavan A, Keith JD, Bastacky SI, et al. The proportion of cores with high-grade prostatic intraepithelial neoplasia on extended-pattern needle biopsy is significantly associated with prostate cancer on site-directed repeat biopsy. BJU Int. 2007;99(4):765–9.

    Article  PubMed  Google Scholar 

  92. Merrimen JL, Jones G, Walker D, et al. Multifocal high grade prostatic intraepithelial neoplasia is a significant risk factor for prostatic adenocarcinoma. J Urol. 2009;182(2):485–90; discussion 90.

    Article  PubMed  Google Scholar 

  93. Fleshner NE, O’Sullivan M, Fair WR. Prevalence and predictors of a positive repeat transrectal ultrasound guided needle biopsy of the prostate. J Urol. 1997;158(2):505–8; discussion 8–9.

    Article  PubMed  CAS  Google Scholar 

  94. Stewart CS, Leibovich BC, Weaver AL, Lieber MM. Prostate cancer diagnosis using a saturation needle biopsy technique after previous negative sextant biopsies. J Urol. 2001;166(1):86–91; discussion 91–2.

    Article  PubMed  CAS  Google Scholar 

  95. Epstein JI, Herawi M. Prostate needle biopsies containing prostatic intraepithelial neoplasia or atypical foci suspicious for carcinoma: implications for patient care. J Urol. 2006;175(3 Pt 1):820–34.

    Article  PubMed  Google Scholar 

  96. Rabets JC, Jones JS, Patel A, Zippe CD. Prostate cancer detection with office based saturation biopsy in a repeat biopsy population. J Urol. 2004;172(1):94–7.

    Article  PubMed  Google Scholar 

  97. Fowler Jr JE, Bigler SA, Miles D, Yalkut DA. Predictors of first repeat biopsy cancer detection with suspected local stage prostate cancer. J Urol. 2000;163(3):813–8.

    Article  PubMed  Google Scholar 

  98. Merrimen JL, Jones G, Srigley JR. Is high grade prostatic intraepithelial neoplasia still a risk factor for adenocarcinoma in the era of extended biopsy sampling? Pathology. 2010;42(4):325–9.

    Article  PubMed  Google Scholar 

  99. Kovi J, Jackson MA, Heshmat MY. Ductal spread in prostatic carcinoma. Cancer. 1985;56(7):1566–73.

    Article  PubMed  CAS  Google Scholar 

  100. McNeal JE, Reese JH, Redwine EA, Freiha FS, Stamey TA. Cribriform adenocarcinoma of the prostate. Cancer. 1986;58(8):1714–9.

    Article  PubMed  CAS  Google Scholar 

  101. McNeal JE, Yemoto CE. Spread of adenocarcinoma within prostatic ducts and acini. Morphologic and clinical correlations. Am J Surg Pathol. 1996;20(7):802–14.

    Article  PubMed  CAS  Google Scholar 

  102. Rubin MA, de La Taille A, Bagiella E, Olsson CA, O’Toole KM. Cribriform carcinoma of the prostate and cribriform prostatic intraepithelial neoplasia: incidence and clinical implications. Am J Surg Pathol. 1998;22(7):840–8.

    Article  PubMed  CAS  Google Scholar 

  103. Wilcox G, Soh S, Chakraborty S, Scardino PT, Wheeler TM. Patterns of high-grade prostatic intraepithelial neoplasia associated with clinically aggressive prostate cancer. Hum Pathol. 1998;29(10):1119–23.

    Article  PubMed  CAS  Google Scholar 

  104. Robinson BD, Epstein JI. Intraductal carcinoma of the prostate without invasive carcinoma on needle biopsy: emphasis on radical prostatectomy findings. J Urol. 2010;184(4):1328–33.

    Article  PubMed  Google Scholar 

  105. Van der Kwast TH, Evans A, Lockwood G, et al. Variability in diagnostic opinion among pathologists for single small atypical foci in prostate biopsies. Am J Surg Pathol. 2010;34(2):169–77.

    Article  PubMed  Google Scholar 

  106. Chan TY, Epstein JI. Follow-up of atypical prostate needle biopsies suspicious for cancer. Urology. 1999;53(2):351–5.

    Article  PubMed  CAS  Google Scholar 

  107. Cheville JC, Reznicek MJ, Bostwick DG. The focus of “atypical glands, suspicious for malignancy” in prostatic needle biopsy specimens: incidence, histologic features, and clinical follow-up of cases diagnosed in a community practice. Am J Clin Pathol. 1997;108(6):633–40.

    PubMed  CAS  Google Scholar 

  108. Iczkowski KA, Bassler TJ, Schwob VS, et al. Diagnosis of “suspicious for malignancy” in prostate biopsies: predictive value for cancer. Urology. 1998;51(5):749–57; discussion 57–8.

    Article  PubMed  CAS  Google Scholar 

  109. Bostwick DG, Srigley J, Grignon D, et al. Atypical adenomatous hyperplasia of the prostate: morphologic criteria for its distinction from well-differentiated carcinoma. Hum Pathol. 1993;24(8):819–32.

    Article  PubMed  CAS  Google Scholar 

  110. Renshaw AA, Santis WF, Richie JP. Clinicopathological characteristics of prostatic adenocarcinoma in men with atypical prostate needle biopsies. J Urol. 1998;159(6):2018–21; discussion 22.

    Article  PubMed  CAS  Google Scholar 

  111. Shah RB, Zhou M, LeBlanc M, Snyder M, Rubin MA. Comparison of the basal cell-specific markers, 34betaE12 and p63, in the diagnosis of prostate cancer. Am J Surg Pathol. 2002;26(9):1161–8.

    Article  PubMed  Google Scholar 

  112. Jiang Z, Woda BA, Wu CL, Yang XJ. Discovery and clinical application of a novel prostate cancer marker: alpha-methylacyl CoA racemase (P504S). Am J Clin Pathol. 2004;122(2):275–89.

    Article  PubMed  CAS  Google Scholar 

  113. Iczkowski KA, MacLennan GT, Bostwick DG. Atypical small acinar proliferation suspicious for malignancy in prostate needle biopsies: clinical significance in 33 cases. Am J Surg Pathol. 1997;21(12):1489–95.

    Article  PubMed  CAS  Google Scholar 

  114. Allen EA, Kahane H, Epstein JI. Repeat biopsy strategies for men with atypical diagnoses on initial prostate needle biopsy. Urology. 1998;52(5):803–7.

    Article  PubMed  CAS  Google Scholar 

  115. Moore CK, Karikehalli S, Nazeer T, et al. Prognostic significance of high grade prostatic intraepithelial neoplasia and atypical small acinar proliferation in the contemporary era. J Urol. 2005;173(1):70–2.

    Article  PubMed  Google Scholar 

  116. Amin MM, Jeyaganth S, Fahmy N, et al. Subsequent prostate cancer detection in patients with prostatic intraepithelial neoplasia or atypical small acinar proliferation. Can Urol Assoc J. 2007;1(3):245–9.

    PubMed  Google Scholar 

  117. Lopez JI. Prostate adenocarcinoma detected after high-grade prostatic intraepithelial neoplasia or atypical small acinar proliferation. BJU Int. 2007;100(6):1272–6.

    Article  PubMed  Google Scholar 

  118. Kronz JD, Shaikh AA, Epstein JI. High-grade prostatic intraepithelial neoplasia with adjacent small atypical glands on prostate biopsy. Hum Pathol. 2001;32(4):389–95.

    Article  PubMed  CAS  Google Scholar 

  119. Eeles RA, Kote-Jarai Z, Giles GG, et al. Multiple newly identified loci associated with prostate cancer susceptibility. Nat Genet. 2008;40(3):316–21.

    Article  PubMed  CAS  Google Scholar 

  120. Eeles RA, Kote-Jarai Z, Al Olama AA, et al. Identification of seven new prostate cancer susceptibility loci through a genome-wide association study. Nat Genet. 2009;41(10):1116–21.

    Article  PubMed  CAS  Google Scholar 

  121. Sciarra A, Di Silverio F, Salciccia S, et al. Inflammation and chronic prostatic diseases: evidence for a link? Eur Urol. 2007;52(4):964–72.

    Article  PubMed  CAS  Google Scholar 

  122. De Marzo AM, Marchi VL, Epstein JI, Nelson WG. Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis. Am J Pathol. 1999;155(6):1985–92.

    Article  PubMed  Google Scholar 

  123. Feneley MR, Young MP, Chinyama C, Kirby RS, Parkinson MC. Ki-67 expression in early prostate cancer and associated pathological lesions. J Clin Pathol. 1996;49(9):741–8.

    Article  PubMed  CAS  Google Scholar 

  124. Wang W, Bergh A, Damber JE. Chronic inflammation in benign prostate hyperplasia is associated with focal upregulation of cyclooxygenase-2, Bcl-2, and cell proliferation in the glandular epithelium. Prostate. 2004;61(1):60–72.

    Article  PubMed  CAS  Google Scholar 

  125. Ruska KM, Sauvageot J, Epstein JI. Histology and cellular kinetics of prostatic atrophy. Am J Surg Pathol. 1998;22(9):1073–7.

    Article  PubMed  CAS  Google Scholar 

  126. Shah R, Mucci NR, Amin A, Macoska JA, Rubin MA. Postatrophic hyperplasia of the prostate gland: neoplastic precursor or innocent bystander? Am J Pathol. 2001;158(5):1767–73.

    Article  PubMed  CAS  Google Scholar 

  127. Macoska JA, Trybus TM, Wojno KJ. 8p22 loss concurrent with 8c gain is associated with poor outcome in prostate cancer. Urology. 2000;55(5):776–82.

    Article  PubMed  CAS  Google Scholar 

  128. Tsujimoto Y, Takayama H, Nonomura N, Okuyama A, Aozasa K. Postatrophic hyperplasia of the prostate in Japan: histologic and immunohistochemical features and p53 gene mutation analysis. Prostate. 2002;52(4):279–87.

    Article  PubMed  CAS  Google Scholar 

  129. Tsujimoto Y, Takakuwa T, Takayama H, et al. In situ shortening of CAG repeat length within the androgen receptor gene in ­prostatic cancer and its possible precursors. Prostate. 2004;58(3):283–90.

    Article  PubMed  CAS  Google Scholar 

  130. Putzi MJ, De Marzo AM. Morphologic transitions between proliferative inflammatory atrophy and high-grade prostatic intraepithelial neoplasia. Urology. 2000;56(5):828–32.

    Article  PubMed  CAS  Google Scholar 

  131. Wang W, Bergh A, Damber JE. Morphological transition of proliferative inflammatory atrophy to high-grade intraepithelial neoplasia and cancer in human prostate. Prostate. 2009;69(13):1378–86.

    Article  PubMed  Google Scholar 

  132. Nakayama M, Bennett CJ, Hicks JL, et al. Hypermethylation of the human glutathione S-transferase-pi gene (GSTP1) CpG island is present in a subset of proliferative inflammatory atrophy lesions but not in normal or hyperplastic epithelium of the prostate: a detailed study using laser-capture microdissection. Am J Pathol. 2003;163(3):923–33.

    Article  PubMed  CAS  Google Scholar 

  133. Billis A, Magna LA. Inflammatory atrophy of the prostate. Prevalence and significance. Arch Pathol Lab Med. 2003127(7):840–4.

    PubMed  Google Scholar 

  134. Anton RC, Kattan MW, Chakraborty S, Wheeler TM. Postatrophic hyperplasia of the prostate: lack of association with prostate cancer. Am J Surg Pathol. 1999;23(8):932–6.

    Article  PubMed  CAS  Google Scholar 

  135. Postma R, Schroder FH, van der Kwast TH. Atrophy in prostate needle biopsy cores and its relationship to prostate cancer incidence in screened men. Urology. 2005;65(4):745–9.

    Article  PubMed  CAS  Google Scholar 

  136. Nakai Y, Nelson WG, De Marzo AM. The dietary charred meat carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine acts as both a tumor initiator and promoter in the rat ventral prostate. Cancer Res. 2007;67(3):1378–84.

    Article  PubMed  CAS  Google Scholar 

  137. Gardner Jr WA, Culberson DE. Atrophy and proliferation in the young adult prostate. J Urol. 1987;137(1):53–6.

    PubMed  Google Scholar 

  138. Castrodeza C. Non-progressive evolution, the Red Queen hypothesis, and the balance of nature. Acta Biotheor. 1979;28(1):11–8.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, St. Bartholomew’s Hospital, Barts Cancer Institute, Queen Mary University of London, Charterhouse Square, London, EC1M 6BQ, UK

    Daniel M. Berney MB BChir, M.A., FRCPath

  2. Centre for Molecular Oncology and Imaging, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK

    Daniel M. Berney MB BChir, M.A., FRCPath

  3. Department of Histopathology, Addenbrooke’s Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, CB2 0QQ, UK

    Anne Y. Warren M.S., B.S., M.Sc., FRCPath

Authors
  1. Daniel M. Berney MB BChir, M.A., FRCPath
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Anne Y. Warren M.S., B.S., M.Sc., FRCPath
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Daniel M. Berney MB BChir, M.A., FRCPath .

Editor information

Editors and Affiliations

  1. New York Presbyterian Hospital, Brady Urologic Health Center, Weill Cornell Medical Center, East 68th Street 525, New York, 10021, New York, USA

    Ashutosh Tewari

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer-Verlag London

About this chapter

Cite this chapter

Berney, D.M., Warren, A.Y. (2013). Premalignant Lesions of the Prostate. In: Tewari, A. (eds) Prostate Cancer: A Comprehensive Perspective. Springer, London. https://doi.org/10.1007/978-1-4471-2864-9_19

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-2864-9_19

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-4471-2863-2

  • Online ISBN: 978-1-4471-2864-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation